Literature DB >> 1445854

Rat insulin-degrading enzyme: cleavage pattern of the natriuretic peptide hormones ANP, BNP, and CNP revealed by HPLC and mass spectrometry.

D Müller1, C Schulze, H Baumeister, F Buck, D Richter.   

Abstract

The degradation of atrial natriuretic peptide (ANP), brain natriuretic peptide (BNP), and C-type natriuretic peptide (CNP) by insulin-degrading enzyme (IDE) has been investigated. As revealed by high-performance liquid chromatography, all three peptides are sequentially cleaved at a limited number of sites, the latter of which were identified by mass spectrometric analyses. The studies revealed that ANP is preferred as substrate over BNP and CNP. ANP degradation is rapidly initiated by hydrolysis at the Ser25-Phe26 bond. Three additional cleavage sites were identified in ANP after prolonged incubation with IDE; in contrast, three and two bonds were hydrolyzed in BNP and CNP, respectively. Analysis of the nine cleavage sites shows a preference for basic or hydrophobic amino acid residues on the carboxyl side of a cleaved peptide bond. In contrast to most of the peptide fragments generated by IDE activity, the initial ANP cleavage product, F-R-Y, is rapidly degraded further by cleavage of the R-Y bond. Cross-linking studies with 125I-ANP in the presence of sulfhydryl-modifying agent indicate that IDE activity is inhibited at the level of initial substrate binding whereas metal-ion chelating agents only prevent hydrolysis. On the basis of its structural and enzymatic properties, IDE exhibits striking similarity to a number of recently-described endopeptidases.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1445854     DOI: 10.1021/bi00160a026

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  22 in total

1.  Purified recombinant insulin-degrading enzyme degrades amyloid beta-protein but does not promote its oligomerization.

Authors:  V Chesneau; K Vekrellis; M R Rosner; D J Selkoe
Journal:  Biochem J       Date:  2000-10-15       Impact factor: 3.857

2.  B-type natriuretic peptide and glycaemia: an emerging cardiometabolic pathway?

Authors:  P Welsh; J J McMurray
Journal:  Diabetologia       Date:  2012-03-08       Impact factor: 10.122

Review 3.  Hepatic Insulin Clearance: Mechanism and Physiology.

Authors:  Sonia M Najjar; Germán Perdomo
Journal:  Physiology (Bethesda)       Date:  2019-05-01

4.  Insulin-degrading enzyme modulates the natriuretic peptide-mediated signaling response.

Authors:  Luis A Ralat; Qing Guo; Min Ren; Todd Funke; Deborah M Dickey; Lincoln R Potter; Wei-Jen Tang
Journal:  J Biol Chem       Date:  2010-11-22       Impact factor: 5.157

Review 5.  Amyloid beta-degrading cryptidases: insulin degrading enzyme, presequence peptidase, and neprilysin.

Authors:  E Malito; R E Hulse; W-J Tang
Journal:  Cell Mol Life Sci       Date:  2008-08       Impact factor: 9.261

6.  Pro-B-type natriuretic peptide-1-108 processing and degradation in human heart failure.

Authors:  Brenda K Huntley; Sharon M Sandberg; Denise M Heublein; S Jeson Sangaralingham; John C Burnett; Tomoko Ichiki
Journal:  Circ Heart Fail       Date:  2014-10-22       Impact factor: 8.790

Review 7.  BNP molecular forms and processing by the cardiac serine protease corin.

Authors:  Tomoko Ichiki; Brenda K Huntley; John C Burnett
Journal:  Adv Clin Chem       Date:  2013       Impact factor: 5.394

Review 8.  Physiological functions of endosomal proteolysis.

Authors:  T Berg; T Gjøen; O Bakke
Journal:  Biochem J       Date:  1995-04-15       Impact factor: 3.857

9.  N-arginine dibasic convertase, a metalloendopeptidase as a prototype of a class of processing enzymes.

Authors:  A R Pierotti; A Prat; V Chesneau; F Gaudoux; A M Leseney; T Foulon; P Cohen
Journal:  Proc Natl Acad Sci U S A       Date:  1994-06-21       Impact factor: 11.205

10.  In vitro degradation of insulin-like peptide 3 by insulin-degrading enzyme.

Authors:  Wei-Jie Zhang; Xiao Luo; Zhan-Yun Guo
Journal:  Protein J       Date:  2010-02       Impact factor: 2.371

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.